­

LOG SERVICE CALL
  • 0

THE VALUE OF CENTRALISED RADIOPHARMACY

  • UNIT DOSE
  • PRODUCT SUPPLY
  • BENEFITS
  • LOCATIONS

UNIT DOSE

GMS Australia extemporaneously compounds SPECT & PET Radiopharmaceuticals made to order by customers for particular persons.


Unit Dose is GMS's complete solution to all of a Nuclear Medicine Department's radiopharmaceutical needs. The Unit Dose Service provides the right dose at the right place at the right time. Unit dose means that individual doses are prepared, quality assured and packaged for each individual scan. Doses are delivered on time to Nuclear Medicine departments for administration to patients.


The unit dose service includes the retrieval, decay and disposal of all radioactive waste from delivered doses. Unit Dose also includes free use of GMS's Secure Insert system, a safe reliable method for handling and disposal of radioactive sharps.


GMS's unit dose services save you time and money. Scientists can schedule patients more efficiently and respond to patients' needs on very short notice. There is no need to purchase bulk materials and mix individual doses on-site, and no need to worry about wasting time-sensitive radioactive materials, since you order only what you need, when you need it.


Unit Dose is the answer to all of your departments radiopharmaceutical needs. Contact one of our Customer Service Staff to find out how UNIT DOSE is the complete solution for your department.


PRODUCT SUPPLY

GMS Australia extemporaneously compounds SPECT & PET Radiopharmaceuticals made to order by customers for particular persons.


Supply mechanisms for FDG follow a standard product supply agreement, whereas other products are supplied under a Clinical Trial / Contract Manufacturing Agreement(s) or utilising the TGA Special Access Scheme or Authorised Prescriber rules.


None of the products being available for supply to the general public, and are only available to hospitals, doctors and certain other authorised persons.

- All SPECT/PET tracers other than FDG are currently considered by TGA to be unapproved medicines.

- All compounded products by GMS Australia are manufactured to GMP standards in a TGA-licenced manufacturing facility. Where a Pharmacopeia Monograph exists, GMS Australia manufactures to that specification.

- All Clinical Trials must have ethics approval in keeping with NH&MRC guidelines, with an appropriate Clinical Trials Notification (CTN) lodged with TGA.

- SAS A, B & C schemes may be used, depending on the tracer and application. See the TGA website for more information. https://www.tga.gov.au/form/special-access-scheme

- GMS Australia must be supplied with copies of the CTNs or appropriate SAS forms

- GMS Australia provides a regular consolidated report to TGA on the use of unapproved products using the special access scheme, which identifies the sites using such products

In addition to the above, GMS Australia and imaging sites need to have a Supply Agreement in place. We can also provide you with more detailed information on the regulatory requirements mentioned above

UNIT DOSE ENQUIRIES

First Name:

Last Name:

Department:

Phone:

Email:

Does your site currently order weekly 99Mo/99mTc Generators?

Current 99Mo/99mTc Generator Activity:

99Mo/99mTc Generator Calibration Day:

99Mo/99mTc Generator Delivery Day:

Message:

BENEFITS



CONVENIENCE





QUALITY





EFFICIENCY



LOCATIONS



CONVENIENCE





QUALITY





EFFICIENCY